Clinical Professor Harry Iland

Clinical Professor
Medicine, Central Clinical School
Kanematsu Laboratories

C39 - Royal Prince Alfred Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9515 7451
F: +61 2 9515 6698
E:

Research interests

His main interests have encompassed molecular abnormalities in haematological malignancies, and he established one of the earliest molecular diagnostic laboratories for haematological malignancy in Australia. In the last few years he has been responsible for the Australasian Leukaemia and Lymphoma Group’s clinical trial program in acute promyelocytic leukaemia (APL), and has combined this with an active laboratory program in the molecular analysis of APL cells. His laboratory has also established molecular assays relevant for patients with idiopathic hypereosinophilic syndrome / chronic eosinophilic leukaemia.

International links

United Kingdom. (Kings College London) Prof David Grimwade - retinoic acid receptor ligand binding domain mutational analysis in relapsed acute promyelocytic leukaemia.
United States. (Robert H. Lurie Comprehensive Cancer Center, Northwestern University) Dr Jessica Altman - planning a multi-cooperative group trial in acute promyelocytic leukemia.
United States. (Memorial Sloan Kettering Cancer Center) Professor Martin Tallman - planning a multi-cooperative group trial in acute promyelocytic leukemia.